KDventures AB (FRA:2I9)

Market Cap	16.65M -19.8%
Revenue (ttm)	134.20K -17.6%
Net Income	-53.42M
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,332
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.0001 - 0.0732
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About KDventures AB

KDventures AB, formerly known as Karolinska Development AB (publ), is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, medical innovations, healthcare technology, gene research and development, innovative drug development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2003
• Employees: 7
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2I9

Financial Performance

In 2025, KDventures AB's revenue was 1.67 million, a decrease of -9.09% compared to the previous year's 1.84 million. Losses were -193.86 million, 2293.0% more than in 2024.

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error